As part of the development of its diagnostics network, multinational pharmaceutical company Lupin Ltd (Lupin) announced the opening of a brand-new, cutting-edge Regional Reference Laboratory in Bengaluru, Karnataka. Given Lupin Diagnostics’ effort to offer accessible and reasonably priced diagnostics and preventive healthcare services across India, the new laboratory represents a significant advancement. The company’s current network of 25 laboratories and more than 410 collection centres across India is supplemented by the Regional Reference Laboratory.
Lupin Diagnostics is able to provide patients and customers in Bengaluru and surrounding cities with high-quality and dependable diagnostic services thanks to the new laboratory’s cutting-edge technology and workforce of highly qualified clinical professionals. The laboratory provides a wide range of diagnostic services, including routine biochemistry, molecular diagnostics, cytogenetics, flow cytometry, cytology, microbiology, serology, haematology, histopathology, immunology, and more, in addition to normal and specialised tests. Lupin Diagnostics uses cutting-edge automation and simplified procedures to give extremely accurate test results, enabling clients to make knowledgeable health decisions.
According to Ravindra Kumar, CEO of Lupin Diagnostics, “ensuring that high-quality diagnostics are available and affordable for everyone in India is at the core of our purpose.” “A precise diagnosis is essential for the efficient management of diseases, and we are dedicated to offering our patients dependable, high-quality diagnostic services. Patients and doctors can acquire important insights into health trends and make well-informed decisions regarding treatment options with the help of our state-of-the-art technology and individualised smart reports, he continued.
Doctors, patients, and consumers can rely on Lupin Diagnostics for an unmatched selection of diagnostic services. Two of the company’s laboratories have already received NABL accreditation, demonstrating its constant dedication to quality and precision. This achievement strengthens Lupin Diagnostics’ position as a reputable leader in the healthcare sector and demonstrates the company’s commitment to excellence in all that it does. An international pharmaceutical firm with a focus on innovation, Lupin is based in Mumbai, India. The company creates and promotes a wide variety of branded and generic formulations, biotechnology products, and APIs in more than 100 markets throughout the US, India, South Africa, and the regions of Asia Pacific (APAC), Latin America (LATAM), Europe, and the Middle East.
